Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Australia Drug Delivery Devices Investment Opportunities

Analysis and Forecasts to 2015

Publication Date March 2009
Publisher Global Markets Direct
Product Type Report
Pages 97
ISBN Number not applicable
Product Code GMD01417

Price

£1,650.00
approximately: $2,498 | €1,842

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an essential source for in-depth information and data relating to the Australia drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Australia

Scope

  • The report provides drug delivery devices information broken down into detailed categories and segments in Australia.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the drug delivery devices market in Australia.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Drug delivery devices
    • 3.2 Needle-free Injections
    • 3.3 Inhalation Systems
      • 3.3.1 Metered Dose Inhaler
      • 3.3.2 Dry powder inhaler
    • 3.4 Infusion Systems
      • 3.4.1 Infusion pumps
      • 3.4.2 Syringe pumps
      • 3.4.3 Disposable Infusion sets
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity Assessment
    • 5.2 Advertising
    • 5.3 Labeling and Packaging
    • 5.4 Post-market Surveillance
    • 5.5 Registration Fee
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 Drug Delivery Devices In Australia
    • 8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
    • 8.3 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
    • 8.4 Drug Delivery Devices, Australia, Company Share (2006-2007)
  • 9 Infusion Systems In Australia
    • 9.1 Infusion Systems Overall Revenue (2000-2015)
    • 9.2 Infusion Systems Overall Volume (2000-2015)
    • 9.3 Infusion Systems Average Price (2000-2015)
    • 9.4 Infusion Systems Distribution Share (2007-2008)
    • 9.5 Infusion Systems, Australia, Company Share (2006-2007)
  • 10 Inhalation Systems In Australia
    • 10.1 Inhalation Systems Overall Revenue (2000-2015)
    • 10.2 Inhalation Systems Overall Volume (2000-2015)
    • 10.3 Inhalation Systems Average Price (2000-2015)
    • 10.4 Inhalation Systems Distribution Share (2007-2008)
    • 10.5 Inhalation Systems, Australia, Company Share (2006-2007)
  • 11 Overview of Key Companies in Australia Drug Delivery Devices Market
    • 11.1 AstraZeneca PLC Company Profile
      • 11.1.1 Company Overview
    • 11.2 Boehringer Ingelheim GmbH Company Profile
      • 11.2.1 Company Overview
      • 11.2.2 Value Chain Analysis
        • 11.2.2.1 Manufacturing
        • 11.2.2.2 Product Development
        • 11.2.2.3 Sales and Marketing
    • 11.3 GlaxoSmithKline plc Company Profile
      • 11.3.1 Company Overview
    • 11.4 Cardinal Health, Inc. Company Profile
      • 11.4.1 Company Overview
      • 11.4.2 Value Chain Analysis
        • 11.4.2.1 Manufacturing
        • 11.4.2.2 Product Development
        • 11.4.2.3 Sales and Marketing
    • 11.5 Baxter International Inc. Company Profile
      • 11.5.1 Company Overview
      • 11.5.2 Value Chain Analysis
        • 11.5.2.1 Manufacturing
        • 11.5.2.2 Product Development
        • 11.5.2.3 Sales and Marketing
    • 11.6 Novartis AG
      • 11.6.1 Company Overview
    • 11.7 Fresenius SE
      • 11.7.1 Company Overview
    • 11.8 Smiths Medical Company Profile
      • 11.8.1 Company Overview
      • 11.8.2 Value Chain Analysis
        • 11.8.2.1 Manufacturing
        • 11.8.2.2 Product Development
        • 11.8.2.3 Sales and Marketing
    • 11.9 Consort Medical plc Company Profile
      • 11.9.1 Company Overview
      • 11.9.2 Value Chain Analysis
        • 11.9.2.1 Manufacturing
        • 11.9.2.2 Product Development
        • 11.9.2.3 Sales and Marketing
      • 11.9.3 Consort Medical plc Pipeline Products
        • 11.9.3.1 Consort Medical plc Pipeline Products By Equipment Type
        • 11.9.3.2 Consort Medical plc Pipeline Products By Development Stage
        • 11.9.3.3 Consort Medical plc Pipeline Products By Therapy Area
    • 11.10 B. Braun Melsungen AG Company Profile
      • 11.10.1 Company Overview
      • 11.10.2 Value Chain Analysis
        • 11.10.2.1 Manufacturing
        • 11.10.2.2 Product Development
        • 11.10.2.3 Research and Development
        • 11.10.2.4 Sales and Marketing
    • 11.11 Hospira, Inc. Company Profile
      • 11.11.1 Company Overview
      • 11.11.2 Value Chain Analysis
        • 11.11.2.1 Manufacturing
        • 11.11.2.2 Product Development
        • 11.11.2.3 Research and Development
        • 11.11.2.4 Sales and Marketing
      • 11.11.3 Hospira, Inc. Pipeline Products
        • 11.11.3.1 Hospira, Inc. Pipeline Products by Equipment Type
        • 11.11.3.2 Hospira, Inc. Pipeline Products by Development Stage
        • 11.11.3.3 Hospira, Inc. Pipeline Products by Therapy Area
    • 11.12 pSivida Limited Company Profile
      • 11.12.1 Company Overview
    • 11.13 Unomedical Pty Ltd Company Profile
      • 11.13.1 Company Overview
  • 12 Recent Developments
    • 12.1 Product News
      • 12.1.1 Dec 12, 2008: pSivida New Clinical Trial for Drug Delivery Device in AMD
      • 12.1.2 Dec 03, 2008: pSivida's BrachySil Pancreatic Cancer Treatment Featured On The BBC
      • 12.1.3 Oct 02, 2008: Results from the Six-Month Interim Readout of the Human PK Iluvien Study
  • 13 Appendix
    • 13.1 Global Markets Direct Research Methodology
    • 13.2 Coverage
    • 13.3 Secondary Research
    • 13.4 Primary Research
    • 13.5 Models
    • 13.6 Forecasts
    • 13.7 Expert Panel Validation
    • 13.8 Currency Conversion
    • 13.9 Contact Us
    • 13.10 Disclaimer
  • 1 List of Tables
    • Table 1: Healthcare Infrastructure in Australia, 2005
    • Table 2: Healthcare Personnel in Australia, 2005
    • Table 3: Hospital Wards by Specialty in Australia, 2003-2007
    • Table 4: Doctors by Specialty in Australia, 2003-2007
    • Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007
    • Table 6: Fee for Registered Device in Australia, 2007
    • Table 7: Fee for Device Clinical Trial in Australia, 2007
    • Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007
    • Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007
    • Table 10: Fee for Registration of Listed Devices in Australia, 2007
    • Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007
    • Table 12: Fee for Registration of Included Devices in Australia, 2007
    • Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007
    • Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007
    • Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
    • Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007
    • Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007
    • Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007
    • Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007
    • Table 22: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 23: Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
    • Table 24: Drug Delivery Devices, Australia, Portfolio Analysis, 2000-2015
    • Table 25: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 26: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 27: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
    • Table 28: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008
    • Table 29: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015
    • Table 30: Drug Delivery Devices, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Infusion Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 32: Infusion Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 33: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Table 34: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 35: Infusion Systems, Australia, Average Price ($), Historic, 2000-2008
    • Table 36: Infusion Systems, Australia, Average Price ($), Forecast, 2008-2015
    • Table 37: Infusion Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 38: Infusion Systems, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 40: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 41: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Table 42: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 43: Inhalation Systems, Australia, Average Price ($), Historic, 2000-2008
    • Table 44: Inhalation Systems, Australia, Average Price ($), Forecast, 2008-2015
    • Table 45: Inhalation Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 46: Inhalation Systems, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 47: Consort Medical plc Pipeline Products by Equipment Type
    • Table 48: Consort Medical plc Pipeline Products By Development Stage
    • Table 49: Consort Medical plc Pipeline Products By Therapy Area
    • Table 50: Hospira, Inc. Pipeline Products by Equipment Type
    • Table 51: Hospira, Inc. Pipeline Products By Development Stage
    • Table 52: Hospira, Inc. Pipeline Products By Therapy Area
    • Table 53: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
    • Figure 2: Healthcare Financing Framework in Australia, 2007
    • Figure 3: Healthcare System in Australia, 2007
    • Figure 4: Classification of Medical Devices in Australia, 2007
    • Figure 5: Classification of Noninvasive Devices in Australia, 2007
    • Figure 6: Classification of Invasive Devices in Australia, 2007
    • Figure 7: Classification of Invasive Devices in Australia, 2007
    • Figure 8: Classification of Active Devices in Australia, 2007
    • Figure 9: Classification of Special Medical Devices in Australia, 2007
    • Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007
    • Figure 11: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 12: Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
    • Figure 13: Drug Delivery Devices, Australia, Portfolio Analysis, 2000-2015
    • Figure 14: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 15: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 16: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
    • Figure 17: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008
    • Figure 18: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015
    • Figure 19: Drug Delivery Devices, Australia, Company Share (%), 2007
    • Figure 20: Infusion Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 21: Infusion Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 22: Infusion Systems, Australia, Company Share (%), 2007
    • Figure 23: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 24: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 25: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 26: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 27: Inhalation Systems, Australia, Company Share (%), 2007
    • Figure 28: Boehringer Ingelheim GmbH Value Chain Analysis
    • Figure 29: Cardinal Health, Inc. Value Chain Analysis
    • Figure 30: Baxter International Inc. Value Chain Analysis
    • Figure 31: Smiths Medical Value Chain Analysis
    • Figure 32: Consort Medical plc Value Chain Analysis
    • Figure 33: B. Braun Melsungen AG Value Chain Analysis
    • Figure 34: Hospira, Inc. Value Chain Analysis
    • Figure 35: Global Markets Direct Methodology
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Primary Research Data